Massachusetts Financial Services CO Regenxbio Inc. Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$17.23 - $21.71 $451,150 - $568,454
-26,184 Reduced 52.94%
23,273 $465,000
Q1 2023

May 10, 2023
BUY
$18.08 - $24.55 $88,790 - $120,565
4,911 Added 11.02%
49,457 $935,000
Q4 2022

Feb 13, 2023
BUY
$20.4 - $24.73 $19,237 - $23,320
943 Added 2.16%
44,546 $1.01 Million
Q3 2022

Nov 09, 2022
BUY
$22.29 - $35.04 $971,910 - $1.53 Million
43,603 New
43,603 $1.15 Million

Others Institutions Holding RGNX

# of Institutions
196
Shares Held
43M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email